Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$1.92M of ROIV shares in the open market
Traded Mar 26, 2026 · Filed Mar 31, 2026
- ~$1.92M
- Reported value · 70K sh @ $27.45
- 43K
- Holds after · shares reported
- +30.8%
- stock since the trade · S&P 500 +20.1%, $27.35 → $35.78 on Oct 5
Why it stands out
A board member of Roivant Sciences sold $1.92M of Roivant Sciences shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 26, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 31, 2026
Director$1M+
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$1,921,500
Shares × reported transaction price
- Timing vs results
48 days after results of Feb 6, 2026, 7 days before results of Apr 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue